Trends in Endocrinology & Metabolism
Featured ReviewLinking the Microbiota, Chronic Disease, and the Immune System
Section snippets
Immunity, the Microbiota, and Chronic Inflammatory Disease
In the past decade, our knowledge of chronic inflammatory disease (CID) has been transformed by a new understanding of the central role of the immune system in driving pathology. The immune system functions as a ‘rheostat for the entire body’, seeking out physiological disturbances (infectious or otherwise) and rectifying them via both inflammatory immune responses and by critical repair/regulatory processes such as the clearance of dead cells and the restoration of the physical barrier 1, 2.
Immune–Microbiota Interaction
Humans exist as metaorganisms consisting of host cells in addition to a vast consortium of microbial organisms that live on all of our barrier tissues. The highest density of organisms lives in the intestine, and these organisms provide a tremendous benefit to the host via the enzymatic processing of complex dietary constituents, such as fiber, into metabolites digestible by the host, in addition to many other enzymatic functions. Often, these enzymatic pathways can involve multiple genes
The Microbiota and Chronic Diseases of the Mucosa
The intestine is home to the largest and most metabolically active microbial community in the human body. Therefore, it is perhaps unsurprising that the predominant inflammatory diseases of the gut, Crohn's disease (CD) and ulcerative colitis, are intertwined with shifts in the microbiota. In both diseases, inflammatory immune responses in the intestine against the microbiota induce shifts toward more aggressive members of the population. The most salient example of this effect is the outgrowth
The Microbiota, Obesity, and Metabolic Syndrome
Obesity and associated pathologies, including type II diabetes (T2D) and dyslipidemia, are a worldwide epidemic and affect an increasing number of people each year. The mechanism of T2D is now believed to be a block in insulin signaling driven by inflammatory cytokines [53]. In lean individuals, the fat is dominated by M2 macrophages, eosinophils, group 2 innate lymphoid cells, and Tregs, all of which contribute in their own way to adipose tissue homeostasis [34]. In obese individuals, the
The Microbiota and Cardiovascular Disease
CVD, and in particular atherosclerosis, is the most common cause of death in high-income countries. The root cause of atherosclerosis is blockages in coronary arteries, which is caused by plaques formed of fat deposits and the development of fat-laden macrophages called foam cells. Development of atherosclerosis has long been associated with diets high in animal fats, cholesterol, and red meat. Recently, Hazen and colleagues 80, 81 have identified that a chemical derivative of red meat,
Modern Life and Changing Host–Microbiota Relationships
As discussed, a multitude of evidence now suggests that shifts in the microbiota toward inflammatory and low diversity states can contribute to chronic disease. One of the primary ways that modern life has changed our relationship with our resident bacteria is the advent of antibiotics. The invention of antibiotics sparked a revolution that fundamentally changed morbidity and mortality associated with bacterial infections. However, it can be argued that antibiotics have been overused as
Concluding Remarks and Future Perspectives
It is now clear that the microbiota acts as a genetically distinct organ that is critical for the enzymatic digestion of food, promotion of immune homeostasis, and prevention of enteric infection. Just like the host-derived organs of the body, the microbiota can be damaged, or, as commonly described, become dysbiotic, leading to a negative impact on dependent host systems. Alterations to the microbiota can certainly contribute to pathology and in cases where these changes include the outgrowth
Acknowledgments
The authors would like to apologize that due to length requirements not all work in this burgeoning field could be discussed and properly cited. This work was supported by NIAID K22 AI108719 (T.W.H.) and the NIH intramural program (V.K.R., I.V-C., and Y.B.). The authors would like to thank K. Gopalakrishna and J. Tometich for critical reading of the manuscript.
References (131)
- et al.
Stress, inflammation, and defense of homeostasis
Mol. Cell
(2014) - et al.
Macrophages in tissue repair, regeneration, and fibrosis
Immunity
(2016) - et al.
Role of the microbiota in immunity and inflammation
Cell
(2014) Microbiota and autoimmunity: exploring new avenues
Cell Host Microbe
(2015)Personalized nutrition by prediction of glycemic responses
Cell
(2015)Effector and memory T cell responses to commensal bacteria
Trends Immunol.
(2013)Foxp3+ T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis
Immunity
(2014)Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism
Cell Metab.
(2016)An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
Cell
(2005)Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells
Cell
(2014)
The role of retinoic acid in tolerance and immunity
Immunity
Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling
Cell
Immunological goings-on in visceral adipose tissue
Cell Metab.
Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis
Cell Host Microbe
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis
Cell
Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis
Cell Host Microbe
Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut
Cell Host Microbe
Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease
Cell
The microbiome in cystic fibrosis
Clin. Chest Med.
Macrophages, immunity, and metabolic disease
Immunity
Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome
Cell Host Microbe
Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice
Cell Host Microbe
Immuno-microbiota cross and talk: the new paradigm of metabolic diseases
Semin. Immunol.
The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease
Cell Metab.
Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation
Cell Host Microbe
Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human
Cell
Activated type 2 innate lymphoid cells regulate beige fat biogenesis
Cell
Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat
Cell
Gut microbiota orchestrates energy homeostasis during cold
Cell
Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk
Cell
Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis
J. Am. Coll. Cardiol.
An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia
Mucosal. Immunol.
Alterations in the gut microbiota associated with HIV-1 infection
Cell Host Microbe
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
Mucosal. Immunol.
The oral microbiome and the immunobiology of periodontal disease and caries
Immunol. Lett.
Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences
Cell
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Proc. Natl. Acad. Sci. U. S. A.
A metagenome-wide association study of gut microbiota in type 2 diabetes
Nature
An obesity-associated gut microbiome with increased capacity for energy harvest
Nature
The role of the commensal microbiota in the regulation of tolerance to dietary allergens
Curr. Opin. Allergy Clin. Immunol.
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Nat. Rev. Microbiol.
Microbiota: host interactions in mucosal homeostasis and systemic autoimmunity
Cold Spring Harb. Symp. Quant. Biol.
What are the consequences of the disappearing human microbiota?
Nat. Rev. Microbiol.
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Nat. Rev. Microbiol.
A human gut microbial gene catalogue established by metagenomic sequencing
Nature
Interactions between the microbiota and the immune system
Science
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Nature
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
EMBO Mol. Med.
Inflammatory bowel disease
Annu. Rev. Immunol.
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10–/– mice
Nature
Cited by (171)
Gut-joint axis: Oral Probiotic ameliorates Osteoarthritis
2024, Journal of Traditional and Complementary MedicineFXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy
2023, Biochemical PharmacologyLong-term human spaceflight and inflammaging: Does it promote aging?
2023, Ageing Research ReviewsIsochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway
2023, International ImmunopharmacologyLiving probiotic biomaterials for osteoporosis therapy
2023, Biomedical TechnologyWorldwide health scenario from the perspective of herbal medicine research
2023, Phytopharmaceuticals and Herbal Drugs: Prospects and Safety Issues in the Delivery of Natural Products